Safety Notice Issued By Boston Scientific (BSX) For AngioJet
Zacks Investment Research | Nov 19, 2019 09:06PM ET
Boston Scientific Corporation (NYSE:BSX) is in the process of conducting a Medical Device Correction of certain AngioJet Ultra Consoles, which were shipped to customers without the required operator’s manual. The company issued an urgent field safety notice to inform the users about the same but is not recalling any products.
However, the news had a negligible impact on the stock price, which was closed at $42.29 on Nov 18, following the surfacing of the safety notice.
Boston Scientific did not witness any adverse impact on the users’ health. It expects none to occur as well.
Few Words on AngioJet
AngioJet is a pharmacomechanical peripheral thrombectomy device that includes active aspiration and Power Pulse lytic delivery. It is designed to treat the widest range of thrombosed (blocked blood) vessels by rapidly restoring blood flow.
The system provides the ability and flexibility to remove the thrombus (a blood clot formed within the vascular system of the body, thus hampering blood flow) and quick restoration of the blood flow. It is easy to use and effectively improves the health condition.
Reason Behind the Safety Notice
Per the company, the AngioJet Ultra consoles meet design specifications and are expected to perform as intended. However, as the consoles contain interactive features, the product performance might be delayed due to the missing operator manual.
Boston Scientific is in the process of dispatching the missing manuals with the field safety notice.
It has strongly advised users to read the field safety notice and also create awareness among other users.
Price Performance
The company’s shares have gained 23.2% in the past year compared with the Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.